SMTIN-T140 is a potent TRAP1 (TNF receptor-associated protein 1) inhibitor with anticancer activity; it induces mitochondrial dysfunction, increases mitochondrial ROS production, and activates AMPK; it effectively inhibits tumor growth in a PC3 prostate cancer xenograft mouse model with minimal in vivo toxicity.